Skip to content

Evaluation of the effect of dexmedetomidine on the incidence of delirium in patients after cardiovascular surgery: A randomized placebo-controlled trial

Evaluation of the effect of dexmedetomidine on the incidence of delirium in patients after cardiovascular surgery: A randomized placebo-controlled trial - Evaluation of the effect of dexmedetomidine on the incidence of delirium

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000030920
Enrollment
140
Registered
2018-01-23
Start date
2019-10-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients more than or equal to 65 years old, who undergo cardiovascular surgery for valvular or coronary artery diseases under cardiopulmonary bypass with cardiac arrest

Interventions

Intervention: Infusion of dexmedetomidine immediately after ICU admission until 2 postoperative day(0.1-0.15 microgram/kg/hr) Control: Infusion of normal saline immediately after ICU admission until

Sponsors

Department of Anesthesiology, Keio University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients more than or equal to 65 years old, who undergo cardiovascular surgery for valvular diseases or coronary artery diseases under cardiopulmonary bypass with cardiac arrest

Exclusion criteria

Exclusion criteria: Patients diagnoses as schizophrenia or depression Patients with liver cirrhosis Patients under dialysis management Patient with heart rate less than 50/min Patients with severe dementia Patient without communication ability

Design outcomes

Primary

MeasureTime frame
The incidence of delirium until 2 postoperative day

Secondary

MeasureTime frame
The incidence of delirium until 5 postoperative day The rate of haloperidol or risperidone use for delirium The duration of invasive mechanical ventilation The rate and duration of noninvasive ventilation The rate of intra-aortic balloon pumping or extracorporeal membrane oxygenation management The rate of duration in which the targetted sedation level evaluated by Richmond agitation sedation scale was achieved The dose of catecholamines used The rate and volume of blood transfusion The degree of pain evaluated by Numerical rating scale during ICU stay Cognitive function evaluated by Mini mental state examination at 7 postoperative day Duration of ICU stay

Countries

Japan

Contacts

Public ContactHiromasa Nagata

Keio University School of Medicine Department of Anesthesiology

ojikino2@a5.keio.jp03-3353-1211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026